{"id":3187,"date":"2025-10-28T08:00:33","date_gmt":"2025-10-28T08:00:33","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=3187"},"modified":"2025-09-02T08:38:03","modified_gmt":"2025-09-02T07:38:03","slug":"claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall","title":{"rendered":"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall"},"content":{"rendered":"<p>A recall of Flutiform 250 micrograms \/ 10 micrograms per actuation pressurised inhalation suspension by CD Pharma Ltd has highlighted a labelling error. This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA.<\/p>\n<p>The Group Action Lawyers specialises in helping affected individuals pursue compensation through group actions when pharmaceutical errors like this occur. This article explores the details of the recall and how people might be <a href=\"https:\/\/www.groupactionlawyers.co.uk\/contact\" target=\"_blank\" rel=\"noopener\"><strong>eligible to generally claim compensation in such circumstances.<\/strong><\/a><\/p>\n<p><!--more--><\/p>\n<h3><strong>Understanding the Incorrect Dose Content Statement Issue<\/strong><\/h3>\n<p>The core problem in this Class 2 Medicines Recall is reportedly the incorrect dose content statement printed on the packaging. According to the official notification from the MHRA, the delivered dose content statement mistakenly lists &#8220;approximately 115 micrograms of fluticasone propionate and 4.5 micrograms of formoterol fumarate dihydrate,&#8221; whereas the correct figures should be &#8220;approximately 230 micrograms of fluticasone propionate and 9 micrograms of formoterol fumarate dihydrate.&#8221;<\/p>\n<p>This error is understood to affect batches including 270185-24062FA-30424, 270186-24065FA-30443, 270774-24082FB-30444, and 269881-24064FA-30425, all with expiry dates in 2026 and distributed starting from late June 2025.<\/p>\n<p>Whilst the MHRA emphasises that the medicine&#8217;s quality remains unaffected and patients should continue use as prescribed, the incorrect dose content statement could lead to confusion among some users and healthcare professionals. Such discrepancies in labelling might contribute to misuse or anxiety.<\/p>\n<h3><strong>Impact on Patients and Healthcare Providers<\/strong><\/h3>\n<p>Patients using Flutiform for asthma or COPD management may have encountered this labelling flaw without realising its implications. The recall advises quarantining and returning affected stock at the wholesale and pharmacy level, but for those who already possess the product, the advice is to proceed with treatment whilst reporting any adverse reactions via the MHRA Yellow Card scheme.<\/p>\n<p>From a legal standpoint, errors like an incorrect dose content statement can erode trust in pharmaceutical products and may entitle affected parties to seek redress. If you have suffered side effects, financial losses from replacing medication, or emotional distress due to such issues, joining a group action could amplify your voice and increase the chances of a successful claim against the responsible parties.<\/p>\n<h3><strong>How Group Actions Work for Pharmaceutical Matters<\/strong><\/h3>\n<p>Group actions, also known as class actions, can allow multiple claimants to band together against a common defendant, such as a pharmaceutical company, for issues stemming from product defects. In cases involving labelling errors, compensation might cover medical expenses, lost wages, or pain and suffering, depending on individual circumstances.<\/p>\n<p>The Group Action Lawyers has handled numerous medical cases, ensuring that victims of negligence receive fair settlements. This recall, published on 24 July 2025 by the <a href=\"https:\/\/www.gov.uk\/drug-device-alerts\/class-2-medicines-recall-flutiform-250-micrograms-slash-10-micrograms-per-actuation-pressurised-inhalation-suspension-cd-pharma-ltd-el-25-a-slash-35?utm_medium=email&amp;utm_campaign=govuk-notifications-topic&amp;utm_source=a726e5d4-c8e3-40a1-8762-ec99de3f74bb&amp;utm_content=immediately\" target=\"_blank\" rel=\"noopener\"><strong>MHRA<\/strong><\/a>, underscores the need for accountability, and we are investigating potential claims related to it.<\/p>\n<p>If you have been affected by a recall and any associated incorrect dose content statement, do not delay\u2014<a href=\"https:\/\/www.groupactionlawyers.co.uk\/contact\" target=\"_blank\" rel=\"noopener\"><strong>contact The Group Action Lawyers today for a free, no-obligation consultation<\/strong>.<\/a><\/p>\n<p>Our experts can assess your eligibility for a group action claim and guide you through the process. <a href=\"https:\/\/www.groupactionlawyers.co.uk\/contact\" target=\"_blank\" rel=\"noopener\"><strong>Call us at 0800 634 7575 or visit our website to start your claim now<\/strong><\/a> and secure the compensation you deserve.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A recall of Flutiform 250 micrograms \/ 10 micrograms per actuation pressurised inhalation suspension by CD Pharma Ltd has highlighted a labelling error. This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA. The Group Action Lawyers specialises in helping affected individuals pursue &hellip; <a href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":3188,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[80,36,1,5,99,27,10],"tags":[14,4,81,16,68,60,61,46,20,11,55,8],"class_list":["post-3187","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-group-actions","category-health","category-latest","category-medical","category-medicines","category-products","category-recalls","tag-class-actions","tag-compensation-claims","tag-group-action","tag-investigations","tag-medical-negligence","tag-medical-product","tag-medical-recall","tag-medicinal-drugs","tag-mhra","tag-news","tag-product-safety","tag-recalls"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall - Group Action Lawyers<\/title>\n<meta name=\"description\" content=\"This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall - Group Action Lawyers\" \/>\n<meta property=\"og:description\" content=\"This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-28T08:00:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"734\" \/>\n\t<meta property=\"og:image:height\" content=\"587\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Author\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Author\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall\"},\"author\":{\"name\":\"Author\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"headline\":\"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall\",\"datePublished\":\"2025-10-28T08:00:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall\"},\"wordCount\":520,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1\",\"keywords\":[\"class actions\",\"compensation claims\",\"group action\",\"investigations\",\"medical negligence\",\"medical product\",\"medical recall\",\"medicinal drugs\",\"mhra\",\"news\",\"product safety\",\"recalls\"],\"articleSection\":[\"Group Actions\",\"Health\",\"Latest\",\"Medical\",\"Medicines\",\"Products\",\"Recalls\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall\",\"name\":\"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall - Group Action Lawyers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1\",\"datePublished\":\"2025-10-28T08:00:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"description\":\"This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1\",\"width\":734,\"height\":587,\"caption\":\"incorrect dose content statement\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles &amp; Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\",\"name\":\"Author\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"caption\":\"Author\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/matt\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall - Group Action Lawyers","description":"This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall","og_locale":"en_GB","og_type":"article","og_title":"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall - Group Action Lawyers","og_description":"This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA.","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall","og_site_name":"Group Action Lawyers","article_published_time":"2025-10-28T08:00:33+00:00","og_image":[{"width":734,"height":587,"url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1","type":"image\/jpeg"}],"author":"Author","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Author","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall"},"author":{"name":"Author","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"headline":"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall","datePublished":"2025-10-28T08:00:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall"},"wordCount":520,"commentCount":0,"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1","keywords":["class actions","compensation claims","group action","investigations","medical negligence","medical product","medical recall","medicinal drugs","mhra","news","product safety","recalls"],"articleSection":["Group Actions","Health","Latest","Medical","Medicines","Products","Recalls"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall","name":"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall - Group Action Lawyers","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#primaryimage"},"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1","datePublished":"2025-10-28T08:00:33+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"description":"This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA.","breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#primaryimage","url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1","width":734,"height":587,"caption":"incorrect dose content statement"},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles &amp; Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b","name":"Author","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","caption":"Author"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/matt"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1","jetpack-related-posts":[{"id":1821,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/drugs-recall-compensation-claims-advice","url_meta":{"origin":3187,"position":0},"title":"Drugs recall compensation claims advice","author":"Author","date":"2nd September 2019","format":false,"excerpt":"Drugs recall compensation claims can form into group and multi-party actions when users have suffered as a result of a problem with the manufacturers or the suppliers. The impact for the victims in these kinds of cases can, of course, be severe; especially if the drugs being recalled are for\u2026","rel":"","context":"In &quot;Group Actions&quot;","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"liver disease drug warning","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/liver-disease-drug-warning-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/liver-disease-drug-warning-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/liver-disease-drug-warning-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/liver-disease-drug-warning-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2643,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/harm-and-loss-from-incorrect-product-information","url_meta":{"origin":3187,"position":1},"title":"Harm and Loss from Incorrect Product Information","author":"Author","date":"31st October 2023","format":false,"excerpt":"In today's world, accurate product information is paramount. When this trust is betrayed due to incorrect product information, it can lead to serious consequences. At The Group Action Lawyers, we specialise in helping individuals seek compensation through group actions in cases involving incorrect product information. Group actions can be a\u2026","rel":"","context":"In &quot;Group Actions&quot;","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"incorrect product information","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-GAL-Lawyer-Professional-Person-Meeting-73-Copy-min.jpg?fit=630%2C501&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-GAL-Lawyer-Professional-Person-Meeting-73-Copy-min.jpg?fit=630%2C501&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-GAL-Lawyer-Professional-Person-Meeting-73-Copy-min.jpg?fit=630%2C501&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":2235,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/compensation-for-medicine-recalls","url_meta":{"origin":3187,"position":2},"title":"Compensation for medicine recalls","author":"Author","date":"25th January 2022","format":false,"excerpt":"You can be entitled to claim compensation for medicine recalls if you have suffered some form of harm or injury arising from an issue with medicines that you have taken. If something has gone wrong and the fault lies with the manufacturer, seller, or even someone administering medicine, you could\u2026","rel":"","context":"In &quot;Group Actions&quot;","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"experts warn of buying diet pills online","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/buying-diet-pills-online-warning.png?fit=1200%2C414&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/buying-diet-pills-online-warning.png?fit=1200%2C414&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/buying-diet-pills-online-warning.png?fit=1200%2C414&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/buying-diet-pills-online-warning.png?fit=1200%2C414&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/buying-diet-pills-online-warning.png?fit=1200%2C414&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":2260,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/mislabelled-products-legal-rights-for-compensation","url_meta":{"origin":3187,"position":3},"title":"Mislabelled products: legal rights for compensation","author":"Author","date":"15th March 2022","format":false,"excerpt":"Anyone who has been harmed as a result of mislabelled products could be entitled to bring a claim for compensation, and we can offer No Win, No Fee legal representation for eligible clients. As Group Action Lawyers, this is the kind of event that we can represent people for. Not\u2026","rel":"","context":"In &quot;Group Actions&quot;","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"drugs alert","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2698,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/in-the-news-carbomer-eye-gels-mhra-recall","url_meta":{"origin":3187,"position":4},"title":"In The News: Carbomer Eye Gels MHRA Recall","author":"Author","date":"23rd January 2024","format":false,"excerpt":"In recent publications, the MHRA has publicised a recall for specific brands of Carbomer Eye Gels due to a potential risk of infection. At The Group Action Lawyers, we understand the concerns and challenges faced by those who could be affected. This article aims to shed light on some of\u2026","rel":"","context":"In &quot;Group Actions&quot;","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"carbomer eye gels","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-Lawyer-Professional-Person-Meeting-45-Copy-min.jpg?fit=695%2C509&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-Lawyer-Professional-Person-Meeting-45-Copy-min.jpg?fit=695%2C509&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-Lawyer-Professional-Person-Meeting-45-Copy-min.jpg?fit=695%2C509&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":2702,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/patient-information-leaflet-errors-and-group-actions","url_meta":{"origin":3187,"position":5},"title":"Claiming Compensation: Patient Information Leaflet Errors and Group Actions","author":"Author","date":"30th January 2024","format":false,"excerpt":"Unveiling the Impact of Patient Information Leaflet Errors: In the world of the importance of healthcare, leaflets play a crucial role in ensuring individuals are well-informed about their medications. Unfortunately, errors in these leaflets can lead to serious consequences, affecting the health and well-being of patients. In this article, we\u2026","rel":"","context":"In &quot;Health&quot;","block_context":{"text":"Health","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/health"},"img":{"alt_text":"patient information leaflet error","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-Lawyer-Professional-Person-Meeting-51.jpg?fit=1200%2C800&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-Lawyer-Professional-Person-Meeting-51.jpg?fit=1200%2C800&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-Lawyer-Professional-Person-Meeting-51.jpg?fit=1200%2C800&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-Lawyer-Professional-Person-Meeting-51.jpg?fit=1200%2C800&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-Lawyer-Professional-Person-Meeting-51.jpg?fit=1200%2C800&ssl=1&resize=1050%2C600 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/3187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=3187"}],"version-history":[{"count":1,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/3187\/revisions"}],"predecessor-version":[{"id":3189,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/3187\/revisions\/3189"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/3188"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=3187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=3187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=3187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}